May 2015—WaveSense, a manufacturer of in vitro diagnostic cell targeting, enrichment, and isolation products for pathology, urology, and oncology, added a product to its line of cell enrichment applications delivered through its patented EpiSep medical product line. The Cell Enrichment from Expressed Prostate Secretions application captures, enriches, and isolates targeted cells contained in prostate secretions obtained through digital rectal examination or digital rectal massage. The EPS is the latest addition to a growing list of EpiSep hybridization slide (HS) targeted cell enrichment and isolation applications, including its Cell Enrichment from Urine (Uro-1) and Cell Enrichment from Bone Marrow (CD138) applications.
WaveSense, 949-341-1980